There is a clear correlation between higher level of SPHK1 and poorer overall survival of the patients with lung cancer, ovarian cancer, clear cell renal cell carcinoma (ccRCC), hepatocellular carcinoma (HCC), and pancreatic cancer (Fig. 10d). Here, SPHK1 is linked to ovarian carcinoma.